Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis

Pediatric Pulmonology

Volumn 47, Issue 10, 2012, Pages 966-972

  McColley, Susanna A ^a   Ren, Clement L ^b   Schechter, Michael S ^c   Regelmann, Warren E ^d   Pasta, David J ^e   Konstan, Michael W ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e ICON CLINICAL RESEARCH   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

child health index; cough; Pseudomonas aeruginosa; symptom onset

Indexed keywords

PANCREAS ENZYME;

ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; COUGHING; CYSTIC FIBROSIS; DRUG USE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SCHOOL CHILD; SYMPTOM; WHEEZING;

AGE OF ONSET; ASTHMA; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; MALE; PANCREAS; PANCREATIC EXTRACTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; RESPIRATORY SOUNDS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84866243036     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22519     Document Type: Article

References (19)

1. Linnane BM, Hall GL, Nolan G, Brennan S, Stick SM, Sly PD, Robertson CF, Robinson PJ, Franklin PJ, Turner SW, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008; 178: 1238-1244.
2. Long FR, Williams RS, Castile RG,. Structural abnormalities in infants and young children with cystic fibrosis. J Pediatr 2004; 144: 154-161.
3. Stick SM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg B, Garratt LW, Gangell CL, De Klerk N, Linnane B, Ranganathan S, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623-628.
4. Konstan MW, Butler SM, Wohl MEB, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ,. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003; 142: 624-630.
5. Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Light MJ, Rabin HR, Regelmann WE, et al. Epidemiologic Study of Cystic Fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol 1999; 28: 231-241.
6. Goldhagen J, Remo R, Bryant T III, Wludyka P, Dailey A, Wood D, Watts G, Livingood W,. The health status of southern children: a neglected regional disparity. Pediatrics 2005; 116: e746-e753.
7. VanDevanter DR, Rasouliyan L, Murphy TM, Morgan WJ, Ren CL, Konstan MW, Wagener JS,. Investigators Coordinators of the Epidemiologic Study of Cystic Fibrosis. Trends in the clinical characteristics of the US cystic fibrosis patient population from 1995-2005. Pediatr Pulmonol 2008; 43: 739-744.
8. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL,. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91-100.
9. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139.
10. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC,. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001; 163: 1331-1337.
11. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML,. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol 2003; 36: 230-240.
12. Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, et al. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Pediatr Pulmonol 2010; 45: 934-944.
13. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M, Brooks JG, Northern New England Cystic Fibrosis Consortium. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol 2002; 33: 99-105.
14. Kulich M, Rosenfeld M, Goss C, Wilmott R,. Improved survival among young patients with cystic fibrosis. J Pediatr 2003; 142: 631-636.
15. Verma N, Bush A, Buchdahl R,. Is there still a gender gap in cystic fibrosis ? Chest 2005; 128: 2824-2834.
16. Watts KD, Seshadri R, Sullivan C, McColley SA,. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population. Pediatr Pulmonol 2009; 44: 594-601.
17. Padman R, McColley SA, Miller DP, Konstan MW, Morgan WJ, Schechter MS, Ren CL, Wagener JS, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007; 119: e531-e537.
18. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiaatt P, McCoy K, McNamara S, Ramsey B, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28: 321-328.
19. VandenBranden SL, McMullen A, Schechter MS, Pasta DJ, Michaelis RL, Konstan MW, Wagener JS, Morgan WJ, McColley SA,. Lung function decline from adolescence to young adulthood in cystic fibrosis. Pediatr Pulmonol 2012; 47: 135-143.